We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Multiple Sclerosis

Journal Scan / Research · February 11, 2021

Effect of Applying Phase 3 Trial Inclusion Criteria to MS Patients in Routine Clinical Care

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Effect of Applying Inclusion and Exclusion Criteria of Phase III Clinical Trials to Multiple Sclerosis Patients in Routine Clinical Care
Mult. Scler. 2021 Jan 20;[EPub Ahead of Print], KO Jalusic, D Ellenberger, P Rommer, A Stahmann, U Zettl, K Berger

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading